NorthWest Biotherapeutics Inc (NWBO)

[Doktornolittle]

That doesn't quite cover everything RBSky. LL presented follow-up data to the early DCVax-L clinicals that shows a 25% survival rate beyond 5 years, and suggested it is now about 6 1/2 years for most of that 25%. An apparent cure for 25% of GBM patients while survival beyond 5 years has typically been about 4%. Wow!!!!

What I worry about, and expected you to bring up is this reported positioning of Woodford and 3M(?) to sell shares. People are acting like that is a good thing here. Why is that a good thing? Woodford was in for the long haul... now not so much?